1. OC-016 Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, double-blinded, randomised, placebo-controlled phase ii trial. (22nd June 2015) Authors: Armstrong, MJ; Gaunt, P; Aithal, GP; Parker, R; Barton, D; Hall, D; Guo, K; Abouda, G; Aldersley, M; Gough, SC; Tomlinson, JW; Brown, R; Hubscher, SG; Newsome, PN Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P351Pretreatment of mesenchymal stem cells does not enhance their recruitment to injured tissue in a model of ischemia-reperfusion injury yet abolishes their anti-inflammatory capabilities. (15th July 2014) Authors: Kavanagh, D; Boulton, A; O'leary, M; Suresh, S; Newsome, PN; Kalia, N Journal: Cardiovascular research Issue: Volume 103(2014)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗